Sihuan Pharmaceutical Holdings Group Ltd
Company Profile
Business description
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the medicine and other medicine segments; and the generic medicine segment which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.
Contact
Zhubang 2000
22nd Floor, Building 4
West Balizhuang, Chaoyang District
Beijing100025
CHNT: +86 1057693700
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
2,667
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,841.90 | 8.30 | 0.09% |
CAC 40 | 7,696.27 | 58.28 | -0.75% |
DAX 40 | 23,787.45 | 146.68 | -0.61% |
Dow JONES (US) | 44,828.53 | 344.11 | 0.77% |
FTSE 100 | 8,822.91 | 0.29 | -0.00% |
HKSE | 23,916.06 | 153.88 | -0.64% |
NASDAQ | 20,601.10 | 207.97 | 1.02% |
Nikkei 225 | 39,810.88 | 24.98 | 0.06% |
NZX 50 Index | 12,766.60 | 62.12 | 0.49% |
S&P 500 | 6,279.35 | 51.93 | 0.83% |
S&P/ASX 200 | 8,603.00 | 7.20 | 0.08% |
SSE Composite Index | 3,472.32 | 11.17 | 0.32% |